nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

03.06.2021 | COVID-19 | Other Articles Zur Zeit gratis

Incidence of Anosmia among Covid 19 patients in India

verfasst von: Prem Aanand, Sumeet Angral, Saurabh Varshney, Ritu Raj

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The pandemic COVID-19 has relentlessly caused havoc to human life since its outbreak in December 2019. The disease has been a challenge for all. The clinical manifestations of Covid-19 ranges from no symptoms at all to severe acute respiratory distress syndrome. Anosmia being one of the important clinical features of COVID-19 has always been overlooked by the Indian population. This formed the background for this study. Aim To identify the incidence of anosmia reported in COVID- 19 patients in India. Materials and Methods Literature search was carried out from January 2020 to March 2021 in databases like PUBMED and Google Scholar using the key words “ANOSMIA”, “HYPOSMIA” and “OLFACTORY DYSFUNCTION” in conjunction with “COVID-19”, “SARS-COV-2”, and “CORONAVIRUS”. Boolean operators were used to narrow and broaden the search. The search yielded sixteen eligible articles. Result The scrutiny of the 16 articles revealed an incidence range of anosmia from 9.2% to 82% and an average anosmia incidence rate of 30.19%. The cumulative incidence rate of anosmia in those studies where objective analysis was done is 52.2% and 16.4% for subjective analysis. Discussion The prevalence of anosmia in Indian population is found to be much lesser than that reported by European countries due to ethnicity or negligence. Objective evaluation of anosmia in COVID-19 patients increases the incidence of anosmia drastically. Hence objective evaluations such as UPIST, SNIFFING STICK test, etc. is to be promoted. This study also Emphasises the lack of common gold standard testing for olfaction like vision and hearing.

Chen N, Zhou M, Dong X, Qu J, Gong FHY et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513CrossRefPubMedPubMedCentral

WHO (2021) WHO coronavirus Disease dashboard. https://covid19.who.int/table.

Villalba NL, Maouche YOM (2020) Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Intern Med 4(7):001641

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez NCJ (2009) Research electronic data capture (REDCap)—a metadata driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42(2):377–81CrossRef

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun (Internet) 87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031CrossRef

Guan W, Ni Z, Hu Y (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720CrossRefPubMed

Krajewska J, Krajewski W, Zub KZT (2020) COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Oto-Rhino-Laryngol 277:1885–1897CrossRef

Keller AMD (2013) Hidden consequences of olfactory dysfunction: a patient report series. BMC ear nose throat Dis 1(13):8CrossRef

Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF et al (1991) Smell and taste disorders, a study of 750 patients from the university of pennsylvania smell and taste center. Arch Otolaryngol Neck Surg 117(5):519–528CrossRef

10.

Nordin SBA (2008) Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Allergy Clin Immunol 1(8):10–15

11.

Van Riel D, Verdijk RKT (2015) The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 2(235):277–287CrossRef

12.

Vaira LA, Salzano G, Deiana GDRG (2020) Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 7(130):1787CrossRef

13.

Suzuki M, Saito KMW (2007) Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 2(117):272–277CrossRef

14.

Centers for Disease Control and Prevention (2020) Coronavirus disease 2019 (COVID-19)—symptoms. Published April 17, 2020. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/ symptoms.html Accessed 22 Apr 2020

15.

Ralli M, Di Stadio AGA et al (2020) Defining the burden of olfactory dysfunction in COVID-19 patients. Eur Rev Med Pharmacol Sci 7(24):3440–3441

16.

Brann DH, Tsukahara TWC (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 6(31):5801CrossRef

17.

Malnic B, Godfrey PA, Buck BL (2004) The human olfactory receptor gene family. Proc Natl Acad Sci USA 101:2584–9CrossRefPubMedPubMedCentral

18.

Lapid H, Shushan S, Plotkin A, Voet H, Roth Y, Hummel T (2011) Neural activity at the human olfactory epithelium reflects olfactory perception. Nat Neurosci 11(14):1455-U132CrossRef

19.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler TES (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2(182):271–280CrossRef

20.

Koul D, Begh RA, Kalsotra P (2021) Olfactory and Gustatory alterations in COVID-19 patients: a tertiary care COVID-19 centre inpatient experience. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-021-02397-zCrossRefPubMed

21.

Fodoulian L, Tuberosa J, Rossier D, Landis BN, Carleton A RI (2020) SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. May 30, 2020. Availablefrom:https://www.researchgate.net/deref/https3A%2F%2Fdoi.org%2F10.1101%2F2020.03.31.013268

22.

Yan R, Zhang Y, Li Y (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science(80-) 367:1444–8

23.

Wrapp D, Wang NCK (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260–3CrossRefPubMedPubMedCentral

24.

Mair M, Singhavi H, Pai A, Singhavi J, Gandhi P, Conboy P, Baker A, Das S (2020) A meta-analysis of 67 studies with presenting symptoms and laboratory tests of COVID-19 patients. Laryngoscope. https://doi.org/10.1002/lary.29207CrossRefPubMed

25.

Prakash A, Singh H, Sarma P et al (2020) nCoV-2019 infection induces neurological outcome and manifestation, linking its historical ancestor SARS-CoV & MERS-CoV: A systematic review and meta-analysis, 17 June 2020; PREPRINT (Version 1) Doi:https://doi.org/10.21203/rs.3.rs-35790/v1

26.

Bidkar V, Mishra M, Selvaraj K, Joshi P, Shrikrishna BH, Dabhekar S et al (2020) Testing olfactory and gustatory dysfunctions among quarantine COVID-19 suspects. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-020-02210-3CrossRefPubMedPubMedCentral

27.

Torabi A, Mohammadbagheri E, Dilmaghani NA, Bayat AH, Fathi M, Vakili K et al (2020) Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS chem neurosci 13(11):1909–13CrossRef

28.

Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T et al (2020) COVID-19 and the chemical senses: supporting players take center stage. Neuron 13(11):219–33CrossRef

29.

Vogalis F, Hegg CCLM (2005) Ionic conductances in sustentacular cells of the mouse olfactory epithelium. Physiol-lond 562(3):785–99CrossRef

30.

Rajkumar I, Anand KH, Revathishree K, Shoba K, Srinivasan K (2020) Contemporary analysis of olfactory dysfunction in mild to moderate COVID 19 patients in a tertiary health care centre. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-020-02175-3CrossRefPubMed

31.

Dev N, Sankar J, Gupta N et al (2021) COVID-19 with and without anosmia or dysgeusia: a case-control study. J Med Virol. https://doi.org/10.1002/jmv.26784CrossRefPubMed

32.

Bhattacharjee AS, Joshi SV, Naik S, Sangle S, Abraham NM (2020) Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers. EClinicalMedicine 28:100575. https://doi.org/10.1016/j.eclinm.2020.100575CrossRefPubMedPubMedCentral

33.

Mishra P, Gowda V, Dixit S, Kaushik M (2020) Prevalence of new onset anosmia in COVID-19 patients: is the trend different between european and indian population? Indian J Otolaryngol Head Neck Surg 72(4):484–7. https://doi.org/10.1007/s12070-020-01986-8CrossRefPubMedPubMedCentral

34.

Klopfenstein T, Kadiane-Oussou NJTL (2020) Features of anosmia in COVID-19. Med Mal Infect 5(50):436–439CrossRef

35.

Lechien JR, Chiesa-Estomba CM, Hans S, Barillari MRJ, JouffeSaussez LS (2020) Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern 173(8):672–675CrossRef

36.

Paderno A, Mattavelli DRV et al (2020) Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects. Otolaryngol Head Neck Surg 163(6):1144–1149CrossRefPubMedPubMedCentral

37.

Tong JY, Wong A, Zhu D, Fastenberg JHTT (2020) The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol 163(1):3–11CrossRef

38.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan. China JAMA Neurol 77(6):683–690CrossRefPubMed

39.

Junpei Komagamine, Taku Yabuki (2020) Initial symptoms of patients with coronavirus disease 2019 in Japan. Doi: https://doi.org/10.21203/rs.3.rs-33323/v1

40.

Rabin RC (2020) Lost sense of smell may be a peculiar clue to corona virus infection. New York Times 3- 22. Available from: https://www.nytim es.com/2020/03/22/health/coronavirus-symptoms-smell-taste .html

41.

Strafella C, Caputo V, Termine A et al (2020) Analysis of ACE2 genetic variability among populations highlights a possible link with COVID19-related neurological complications. Genes. https://doi.org/10.21203/rs.3.rs-28871/v1CrossRefPubMedPubMedCentral

42.

Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M (2020) The new coronavirus epidemic evidence for virus evolution. J Med Virol 4(92):455–9CrossRef

43.

Lechien JR, Chiesa-Estomba CM, De Siati DR et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 277(8):2251–2261CrossRefPubMedPubMedCentral

44.

Li W, Zhang CSJ et al (2020) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBOJ 8(24):1634–43

45.

Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R (2020) Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci 11(11):1555–1562CrossRefPubMed

46.

Sahoo PR, Sahu M, Surapaneni PS, Maiti A, Vankamamidi R, Panda N, Biswal RN (2021) Evolution of olfactory and gustatory dysfunctions in COVID-19 patients in India. Eur Arch Otorhinolaryngol 3:1–7

47.

Beltra´n-Corbellini A et al (2020) Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case—control study. Eur J Neurol 9(27):1738–41CrossRef

48.

Keyhan SO, Fallahi HR, Cheshmi B (2020) Dysosmia and dysgeusia due to the 2019 novel coronavirus; a hypothesis that needs further investigation. Maxillofac Plast Reconstr Surg 42:9. https://doi.org/10.1186/s40902-020-002547CrossRefPubMedPubMedCentral

49.

Jain A, Kumar L, Kaur J, Baisla T, Goyal P, Pandey AK et al (2020) Olfactory and taste dysfunction in coronavirus disease 2019 patients: Its prevalence and outcomes. J Laryngol Otol 134(11):987–91CrossRef

50.

Thakur K, Sagayaraj A, Prasad KC, Gupta A (2021) Olfactory dysfunction in COVID-19 patients findings from a tertiary rural centre. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-021-02364-8CrossRefPubMedPubMedCentral

51.

Panda S, Mohamed A, Sikka K, Kanodia A, Sakthivel P, Thakar A et al (2020) Otolaryngologic manifestation and long-term outcome in mild COVID-19: experience from a tertiary care centre in India. Indian J Otolaryngol Head Neck Surg. https://doi.org/10.1007/s12070-020-02217-wCrossRefPubMedPubMedCentral

52.

Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A (2013) Riechstörungen: Häufig im alter und wichtiges frühsymptom neurodegenerativer erkrankungen. Dtsch Arztebl Int 110(1–2):1–8PubMedPubMedCentral

53.

Meng X, Deng Y, Dai Z, Meng Z (2020) COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol 41(5):102581. https://doi.org/10.1016/j.amjoto.2020.102581CrossRefPubMedPubMedCentral

Titel: Incidence of Anosmia among Covid 19 patients in India
verfasst von: Prem Aanand
Sumeet Angral
Saurabh Varshney
Ritu Raj
Publikationsdatum: 03.06.2021
Verlag: Springer India
Schlagwort: COVID-19
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-021-02641-6

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Incidence of Anosmia among Covid 19 patients in India

Abstract

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2022

Evaluation of the Role of Toluidine Blue Paint as an Adjunctive Method to Biopsy in Suspicious Oral Lesion: A Hospital Based Study

Comparison of Diagnostic Reliability of p63 and Smooth Muscle Actin in Salivary Gland Neoplasms

Of Eagle’s Syndrome and Finding Some Clarity on Its Management

Elective Neck Dissection Versus Observation in cT1–T2 Oral Tongue Squamous Cell Carcinoma: A Meta-Analysis of 11,973 Patients

Deep Neck Space Infections: Current Trends and Intricacies of Management?

Outcome of Submucosal Inferior Turbinoplasty in Perennial Allergic Rhinitis

Neu im Fachgebiet HNO

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Nur selten Nachblutungen nach Abszesstonsillektomie

Rezidivierender Peritonsillarabszess nach Oralsex

Update HNO